Doctor profile · Federal record
Dr. RICHARD STECKLEY, M.D.
Cardiovascular Disease Physician (CMS: CARDIOVASCULAR DISEASE (CARDIOLOGY)) · WICHITA, KS
- NPI 1689637092
- Accepts Medicare
- MIPS 80.5 / 100 · 2023
- 52 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
9350 E 35TH ST N, STE 101
WICHITA, KS 672262019
(316) 265-1308
fax (316) 712-9286
Credentials & registration
- NPI registered
- April 2006 — 20 yrs on file
- Profile last updated
- March 23, 2021
- Year of graduation
- 1974 — 52 yrs since
- Specialty taxonomy
- 207RC0000X — NUCC code
- State license (1)
- Kansas #0418666
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1689637092. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
7,055
Distinct HCPCS
10
Medicare allowed
$661,593
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 1,474 | 1,003 | $118 | |
93296 |
Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 830 | 260 | $20 | |
93294 |
Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 789 | 245 | $28 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 520 | 232 | $74 | |
93306 |
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 463 | 439 | $161 | |
A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose | 366 | 180 | $108 | |
J2785 |
Injection, regadenoson, 0.1 mg | 348 | 86 | $52 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 323 | 290 | $83 | |
36415 |
Insertion of needle into vein for collection of blood sample | 214 | 81 | $8 | |
93015 |
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 191 | 188 | $57 |
In context: peer comparison
Among 11 peers in this city , average services per provider: 266. This provider delivers 27× the peer median.Open Payments
Industry payments received
All-time total
$686
Transactions
26
Manufacturers
12
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Medtronic, Inc. | 3 | $269.57 | |
| Merck Sharp & Dohme LLC | 6 | $94.93 | |
| Novartis Pharmaceuticals Corporation | 3 | $68.77 | |
| E.R. Squibb & Sons, L.L.C. | 4 | $67.53 | |
| Novo Nordisk Inc | 3 | $58.19 | |
| Actelion Pharmaceuticals US, Inc. | 1 | $25.17 | |
| LeMaitre Vascular, Inc. | 1 | $18.18 | |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $18.12 | |
| Amgen Inc. | 1 | $17.92 | |
| Regeneron Healthcare Solutions, Inc. | 1 | $16.77 | |
| Janssen Pharmaceuticals, Inc | 1 | $15.69 | |
| AstraZeneca Pharmaceuticals LP | 1 | $14.97 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
9,333
Patients
2,166
Total drug cost
$1,039,321
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Atorvastatin Calcium | Generic | 1,039 | 245 | $9,483 |
| Metoprolol Tartrate | Generic | 1,010 | 244 | $7,318 |
| Metoprolol Succinate | Generic | 928 | 215 | $11,924 |
| Eliquis (Apixaban) | Brand | 843 | 146 | $687,311 |
| Amlodipine Besylate | Generic | 740 | 181 | $4,722 |
| Carvedilol | Generic | 612 | 144 | $4,865 |
| Potassium Chloride | Generic | 558 | 137 | $15,221 |
| Clopidogrel (Clopidogrel Bisulfate) | Brand | 557 | 137 | $7,389 |
| Diltiazem 24hr Er (Cd) (Diltiazem Hcl) | Brand | 506 | 123 | $12,006 |
| Furosemide | Generic | 493 | 131 | $2,644 |